Le Lézard3d
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company"), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot ...
pharmaphorum23d
Merck preps filings for oral COVID drug, but is it really a game changer?
Merck & Co is on the brink of ... At the moment drugs like dexamethasone and Gilead Sciences' intravenous antiviral Veklury (remdesivir) can be used in hospitals to reduce mortality in severe ...
Business Wire2d
Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE ... of new options across multiple drug classes to help those impacted by HIV. Today, we are developing a series of antiviral options designed to ...
5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...
Seeking Alpha24d
Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank
Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, and downgraded Merck (NYSE ... long-acting HIV drugs, including GILD ...
C&EN24d
Long COVID studies stymied by pharma’s lack of cooperation
With both the Merck and the BMS drugs, Nath's studies would have been ... has funded studies testing the antiviral Paxlovid, intravenous immunoglobulin, the heart rate-slowing medication ...
pharmaphorum1d
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy. The EMA’s human ...
Le Lézard2d
Exein partners with Supermicro to redefine the future of embedded security
Exein, the embedded IoT cybersecurity company, and Supermicro, a global leader in application-optimized total IT solutions, have announced a partnership to redefine embedded security. Exein and ...
Yahoo Finance9d
Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight
Notable interferons companies such as Bayer AG, Amega Biotech, Biogen, Merck KGaA, Novartis AG ... COVID-19 based on its most ...
DelveInsight Business Research, LLP: Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight
The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...